LEXINGTON, Mass., Feb. 25, 2015 /PRNewswire/ -- Synageva BioPharma Corp. (Synageva) GEVA, a biopharmaceutical company developing therapeutic products for rare diseases, announced today its presentation at the upcoming Cowen and Company 35th Annual Health Care Conference in Boston, MA.
Sanj K. Patel, President and Chief Executive Officer of Synageva, will present on Tuesday, March 3, 2015, at 8:00 a.m. EST. The presentation will be webcast live and may be accessed from the Investor Relations section of Synageva's website at www.synageva.com.
Synageva routinely posts information that may be important to investors in the Investor Relations section of the company's website at www.synageva.com. Synageva encourages investors and potential investors to consult this website regularly for important information about the company.
Further information regarding Synageva is available at www.synageva.com.
"Synageva BioPharma™" is a trademark, and "Dedicated to Rare Diseases®" is a registered trademark, of Synageva BioPharma Corp.
Logo - http://photos.prnewswire.com/prnh/20140522/90728
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/synageva-biopharma-to-present-at-the-cowen-and-company-health-care-conference-300041286.html
SOURCE Synageva BioPharma Corp.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.